“新净界漱口水”对放射性口腔黏膜炎的防治效果观察

上海口腔医学 ›› 2014, Vol. 23 ›› Issue (6): 727-730.

“新净界漱口水”对放射性口腔黏膜炎的防治效果观察

徐璇丽, 叶晨, 张霖, 李烿烿, 邵滋旸, 涂文勇

上海交通大学医学院附属第九人民医院·口腔医学院口腔颌面-头颈肿瘤科, 上海市口腔医学重点实验室,上海 200011

收稿日期:2013-11-27 修回日期:2014-02-11 出版日期:2014-12-20 发布日期:2015-01-08
通讯作者: 涂文勇,Tel：021-23271699-5663,E-mail：TUWY1233@2m9h.net E-mail:xuxuanli08@gmail.com
作者简介:徐璇丽（1984-）,女,硕士,住院医师

Effect of “Xinjingjie mouthrinse” on prevention and treatment of radiation-induced oral mucositis

XU Xuan-li, YE Chen, ZHANG Lin, LI Rong-rong, SHAO Zi-yang, TU Wen-yong

Department of Oromaxillofacial Head and Neck Oncology, Ninth People’s Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine; Shanghai Key Laboratory of Stomatology. Shanghai 200011, China

Received:2013-11-27 Revised:2014-02-11 Online:2014-12-20 Published:2015-01-08

摘要/Abstract

摘要： 目的：前瞻性随机双盲研究“新净界漱口水”对放射性口腔黏膜炎的防治效果。方法：60例拟行放疗的口腔癌患者随机分为试验组和对照组;试验组30例,自放疗第1天起,每天使用“新净界漱口水”含漱4次,每次5 mL,含漱 5 min,直至放疗结束。对照组30例使用生理盐水含漱,方法同试验组。按RTOG口腔黏膜炎分级标准评价2组患者的口腔黏膜炎严重程度,记录疼痛程度,并照相存档。3级口腔黏膜炎视为终止指标,发生者给予其他药物治疗。应用Stata 12.0软件包对数据进行统计分析。结果：2组患者的年龄、性别、放疗技术和剂量无显著差异（P>0.05）。试验组首次观察到黏膜炎的发生时间较对照组晚（照射11.0次∶9.1次,P<0.05）,且试验组在早期出现疼痛的比例较对照组低（36.7%∶70.0%,P<0.05）。另外,试验组3级口腔黏膜炎的出现时间较对照组晚（照射18.9次∶15.9次,P<0.05）,发生率较对照组低（63.3%∶90.0%,P<0.05）。结论：“新净界漱口水”能延缓放疗所致口腔黏膜炎的发生时间,减轻患者的疼痛症状,并能减少3级口腔黏膜炎的发生率,值得临床使用。

关键词: 口腔黏膜炎, 口腔癌, 放射治疗

Abstract: PURPOSE: To investigate the effect of "Xinjingjie compound lysostaphin antibacterial collutorium" on prevention and treatment of radiation-induced oral mucositis in a prospective, randomized and double-blind clinical trial. METHODS: Sixty patients with oral cancer to be treated with radiotherapy were randomized into the experimental and control group. The experimental group (30 patients) was treated with "Xinjingjie mouthrinse" during the full course of radiotherapy, 4 times daily with 5 mL and 5 min each time. The control group (30 patients) rinsed the mouth in the same way with normal saline. Oral mucositis was assessed according to the RTOG criteria. The severity of mucositis and the degree of pain were recorded and photographed. Patients shouldn't be treated with other drugs until the level of oral mucositis reached above grade III. The results were statistically analyzed using Stata 12.0 software packages. RESULTS: Age, gender, radiotherapy techniques and dose showed no significant difference between the 2 groups (P>0.05). The first onset of oral mucositis in the experimental group was later than that in the control group (11.0 times:9.1 times,P<0.05), and the incidence of pain at the early time of radiotherapy was lower (36.7%: 70.0%, P<0.05). Also, the onset time of grade III oral mucositis in the emperimental group was later than that in the control group (18.9 times：15.9 times,P<0.05), and the incidence of grade III oral mucositis in the experimental group was lower (63.3% vs. 90.0%, P<0.05). CONCLUSIONS: “Xinjingjie mouthrinse” is worthwhile to be used in clinic because it can delay the occurrence time of radiation-induced oral mucositis, alleviate pain and reduce the indication of grade III oral mucositis.

Key words: Oral mucositis, Oral cancer, Radiotherapy

中图分类号:

R781.5

徐璇丽, 叶晨, 张霖, 李烿烿, 邵滋旸, 涂文勇. “新净界漱口水”对放射性口腔黏膜炎的防治效果观察[J]. 上海口腔医学, 2014, 23(6): 727-730.

XU Xuan-li, YE Chen, ZHANG Lin, LI Rong-rong, SHAO Zi-yang, TU Wen-yong. Effect of “Xinjingjie mouthrinse” on prevention and treatment of radiation-induced oral mucositis[J]. Shanghai Journal of Stomatology, 2014, 23(6): 727-730.

参考文献

[1] Saunders DP, Epstein JB, Elad S, et al. Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients [J]. Support Care Cancer, 2013, 21(11): 3191-3207.
[2] Radvansky LJ, Pace MB, Siddiqui A. Prevention and management of radiation-induced dermatitis, mucositis, and xerostomia [J]. Am J Health Syst Pharm, 2013, 70(12): 1025-1032.
[3] Babaee N, Moslemi D, Khalilpour M, et al. Antioxidant capacity of calendula officinalis flowers extract and prevention of radiation induced oropharyngeal mucositis in patients with head and neck cancers: a randomized controlled clinical study [J]. Daru, 2013, 21(1): 18.
[4] Jayachandran S, Balaji N. Evaluating the effectiveness of topical application of natural honey and benzydamine hydrochloride in the management of radiation mucositis [J]. Indian J Palliat Care, 2012, 18(3): 190-195.
[5] Roopashri G, Jayanthi K, Guruprasad R. Efficacy of benzydamine hydrochloride, chlorhexidine, and povidone iodine in the treatment of oral mucositis among patients undergoing radiotherapy in head and neck malignancies: a drug trail [J]. Contemp Clin Dent, 2011, 2(1): 8-12.
[6] Rosenthal DI, Trotti A. Strategies for managing radiation-induced mucositis in head and neck cancer [J]. Semin Radiat Oncol, 2009, 19(1): 29-34.
[7] Ps SK, Balan A, Sankar A, et al. Radiation induced oral mucositis [J]. Indian J Palliat Care, 2009, 15(2): 95-102.
[8] Hong JP, Lee SW, Song SY, et al. Recombinant human epidermal growth factor treatment of radiation-induced severe oral mucositis in patients with head and neck malignancies [J]. Eur J Cancer Care (Engl), 2009, 18(6): 636-641.
[9] Volpato LE, Silva TC, Oliveira TM, et al. Radiation therapy and chemotherapy-induced oral mucositis [J]. Braz J Otorhinolaryngol, 2007, 73(4): 562-568.
[10] Acute radiation morbidity scoring criteria [OL].[2013-02-11] http://www.rtog.org.
[11] 杜清华, 王仁生. 放射性口腔黏膜炎的发病过程 [J]. 国际肿瘤学杂志, 2011, 38(6): 465-467.
[12] 李瑛, 李慧兰, 路婉瑛, 等. FE溶菌酶含片治疗口腔炎性疾患的临床疗效观察 [J]. 山西医科大学学报, 1999, 30(2): 171-172.
[13] 黄青山, 陆婉英, 励俊. 生物溶菌酶在口腔病防治中的应用 [J]. 临床口腔医学杂志, 2002, 18(6): 469-470.
[14] 李会静. 新净界治疗小儿溃疡性口炎疗效观察 [J]. 山西医药杂志, 2007, 1(1): 23.
[15] 关树梅, 张红. 新净界应用于糖尿病口腔护理的效果观察 [J]. 中国美容医学, 2011, 20(z1): 54.